EWTX - Edgewise Therapeutics, Inc.

Over the past 90 days, insiders at Edgewise Therapeutics, Inc. (EWTX) have been net sellers, shedding 43,429 shares worth roughly $1.9M on balance.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kevin Koch	52.5K	$1.98M	-
Other	Behrad Derakhshan	31.8K	$1.20M	-
Other	Alan J Russell	31.5K	$1.19M	-
Dir	Jonathan C Fox	25.1K	$947.3K	-
Dir	Badreddin Edris	19.8K	$746.8K	-

Buys and sells only

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 2, 2023	Kevin Koch51	President and CEO	Sale+OE	3,203	$8.90	$28,522.39	-30.8%	-16.7%	+117.3%
Oct 3, 2022	John R Moore	General Counsel	Sale+OE	4,730	$9.76	$46,154.87	-61.2%	-9.6%	-40.1%
Sep 16, 2022	Orbimed Advisors LLC68	Director, 10% Owner	Buy	484,496	$10.32	$4,999,998.72	+3.6%	-18.9%	-33.0%
Sep 16, 2022	Peter A. Thompson64	Director, 10% Owner	Buy	484,496	$10.32	$4,999,998.72	+3.6%	-18.9%	-33.0%
Sep 14, 2022	Novo Holdings A/s57	10% Owner	Buy	484,496	$10.32	$4,999,998.72	+8.7%	-23.8%	-35.7%
Sep 6, 2022	John R Moore	General Counsel	Sale+OE	4,730	$10.91	$51,597.72	-61.2%	-15.8%	-38.1%
Aug 3, 2022	John R Moore	General Counsel	Sale+OE	9,232	$9.31	$85,921.30	-75.5%	+2.6%	-28.8%
Jul 6, 2022	John R Moore	General Counsel	Sale+OE	9,232	$8.37	$77,256.36	-75.5%	+23.7%	-9.1%
Jun 21, 2022	John R Moore	General Counsel	Sale+OE	67,927	$6.83	$463,934.93	-95.8%	+20.5%	+7.7%
Jun 15, 2022	John R Moore	General Counsel	Sale+OE	26,381	$6.08	$160,456.51	-89.8%	+67.0%	+41.1%